{
    "paper_id": "0f83cae8534eed2a09b5142c0a9cb52a1a0cb4cf",
    "metadata": {
        "title": "TITLE PAGE 1 2",
        "authors": [
            {
                "first": "Samira",
                "middle": [],
                "last": "Davalbhakta",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Byramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals",
                    "location": {
                        "settlement": "Pune",
                        "country": "India"
                    }
                },
                "email": ""
            },
            {
                "first": "Shailesh",
                "middle": [],
                "last": "Advani",
                "suffix": "",
                "affiliation": {
                    "laboratory": "Social Behavioural Research Unit",
                    "institution": "National Institutes of Health",
                    "location": {
                        "addrLine": "11 Bethesda",
                        "settlement": "Maryland",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": ";",
                "middle": [],
                "last": "Shobhit Kumar",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "King George's Medical University",
                    "location": {
                        "settlement": "Lucknow",
                        "country": "India"
                    }
                },
                "email": ""
            },
            {
                "first": "Vishwesh",
                "middle": [],
                "last": "Agarwal",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Mahatma Gandhi Missions Medical College",
                    "location": {
                        "addrLine": "Navi Mumbai",
                        "country": "India 14"
                    }
                },
                "email": ""
            },
            {
                "first": ";",
                "middle": [],
                "last": "Samruddhi Bhoyar",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Massachusetts",
                    "location": {
                        "settlement": "Amherst",
                        "region": "Massachusetts",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Elizabeth",
                "middle": [],
                "last": "Fedirko",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Massachusetts",
                    "location": {
                        "settlement": "Amherst",
                        "region": "Massachusetts",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": ";",
                "middle": [],
                "last": "Durga",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Prasanna",
                "middle": [],
                "last": "Misra",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Ashish",
                "middle": [],
                "last": "Goel",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Latika",
                "middle": [],
                "last": "Gupta",
                "suffix": "",
                "affiliation": {},
                "email": "-drlatikagupta@gmail.com"
            },
            {
                "first": "",
                "middle": [],
                "last": "Dm",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Vikas",
                "middle": [],
                "last": "Agarwal",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Frcp",
                "middle": [
                    "7"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [
        {
            "text": "The global impact of COVID-19 pandemic has increased the need to rapidly develop and improve utilization of 64 mobile applications across the healthcare continuum to address rising barriers of access to care due to social 65 distancing challenges and allow continuity in sharing of health information, assist with COVID-19 activities 66 including contact tracing, and providing useful information as needed. Here we provide an overview of mobile 67 applications being currently utilized for COVID-19 related activities. We performed a systematic review of the 68 literature and mobile platforms to assess mobile applications been currently utilized for COVID-19, and quality 69 assessment of these applications using the Mobile Application Rating Scale (MARS) for overall quality, 70 Engagement, Functionality, Aesthetics, and Information. Finally, we provide an overview of the key salient 71 features that should be included in mobile applications being developed for future use. Our search identified 63 72 apps that are currently being used for COVID-19. Of these, 25 were selected from the Google play store and",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Apple App store in India, and 19 each from the UK and US. 18 apps were developed for sharing up to date 74 information on COVID-19, and 8 were used for contact tracing while 9 apps showed features of both. On 75 MARS Scale, overall scores ranged from 2.4 to 4.8 with apps scoring high in areas of functionality and lower in 76 Engagement. Future steps should involve developing and testing of mobile applications using assessment tools 77 like the MARS scale and the study of their impact on health behaviors and outcomes.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "78 79 80 81 82 83 All rights reserved. No reuse allowed without permission.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Background",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "As the Covid-19 pandemic unfolds, it becomes imperative to expand public health activities to estimate the 85 epidemiology for this virus and assess its short term and long term impacts. 1 This medical disaster necessitates 86 innovative solutions to address unmet needs as the disease continues to evolve and infect people globally. 2",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Collection of adequate exposure information, characterizing disease burden and dissemination of information 88 that helps with prevention, containment and contact tracing are vital to supporting public health efforts. In such 89 situations, the use of mobile health applications facilitates self-guided collection of population-level data, 90 delivery of information, addresses knowledge gaps, prevents the spread of misinformation, navigate individuals 91 to accurate and validated health resources. 3 92 Mobile applications provide a unique opportunity in terms of its ability to allow distant connectivity 93 with flexibility of function, design and accessibility. 4 Current estimates suggest that the global usage of 94 smartphones stands at 3.5 billion as of June 2020 that provides a large userbase to help coordinate and 95 implement mobile interventions to disseminate and help with pandemic response. 5,6 For example, the 96 Singaporean government released a mobile phone app, TraceTogether, that is designed to assist health officials 97 in tracking down exposures after an infected individual is identified. 7 Further, Israel passed a legislation to 98 allow the Government to track people with suspected infection through access of their mobile phone data. 8 In 99 the U.S. recent legislations have expanded scope of telemedicine to involve use of mobile applications for 100 healthcare and preventive reasons. 9 Numerous applications have already been developed globally and are 101 available on the website ((see https://mhealth-hub.org/mhealth-solutions-against-covid-19) . In the U.S and UK, 102 the COVID Symptom tracker app developed with the Coronavirus Pandemic Epidemiology Consortium (COPE) 103 is being widely used to track COVID-related exposure and infections. 10 However, the downside of this involves 104 access to a large number of applications, some of which can be sources of misinformation or information 105 overload thereby creating barriers to containment and mitigation efforts. Moreover, no universal guidelines exist 106 to ensure quality of these mobile applications to a gold standard.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "107 Our current project aims to provide a systematic review of the literature on mobile 108 applications with multiple function including: information dissemination (ID), ID with symptom checking 109 (SSC), contact tracing alone, SSC, training health care workers, disinfection checklist, and service Apps around",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "110 COVID-19. Further, we provide an overall rating of the quality of the apps using The Mobile App Rating Scale 111 (MARS) 11 , a standardized metric, after providing an overview of their functions. 112 113 All rights reserved. No reuse allowed without permission.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. : medRxiv preprint 130 excluded. Two reviewers each, based across the United Kingdom, United States and India and with access to 131 these applications performed a comprehensive assessment of these mobile applications. Discrepancies 132 regarding selection of apps were resolved by a third reviewer in order to reach a consensus.. (Supplementary   133   Table 1 ).",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 460,
                    "end": 490,
                    "text": "(Supplementary   133   Table 1",
                    "ref_id": null
                }
            ],
            "section": "Abstract"
        },
        {
            "text": "Subsequently, data was extracted from each app (Supplementary Table 2 ) and each app was assessed 135 using the MARS rating scale. 11 The MARS evaluation tool is divided into three broad sections-App overall 136 quality, App subjective quality, and App specific quality. It consists of twenty-three questions that are designed 137 to help analyse engagement, functionality, aesthetics, information, and subjective quality of the mobile 138 applications. In addition, there are six final app specific questions that can be tailored to represent the target 139 health behaviour/ function of the application/study (Figure 2) . The mean scores for each of the four subscales 140 (Engagement, Functionality, Aesthetics, and Information) was calculated, and the mean scores of those 141 subsections, used to rate the total quality score of the app ranged from zero to five. Hence the overall score on 142 these subscales would range from 0 to 5 and we would develop an average score by dividing the total sum score 143 All rights reserved. No reuse allowed without permission.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 62,
                    "end": 69,
                    "text": "Table 2",
                    "ref_id": null
                },
                {
                    "start": 611,
                    "end": 621,
                    "text": "(Figure 2)",
                    "ref_id": null
                }
            ],
            "section": "Abstract"
        },
        {
            "text": "was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "English or Hindi were included in the study. Those applications that were duplicates and pay to download were by 4 i.e. 4 domains. The App subjective quality section and App specific section was calculated similarly.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "of MARS using a 37-minute video available on YouTube 12 which was followed by an independent review 146 exercise of a common app and discussion of scores to assess consensus. Disagreements were discussed with a 147 third reviewer, and ambiguous MARS items were clarified to ensure full comprehension of the scale. 11 148 Statistical analysis 149 Unpaired students t-test was performed to analyse the difference in the means obtained in each section by Asian, ",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "The screening process was conducted by two review team members using the keywords: \"Covid\", 160 \"Corona\", \"Pandemic\", \"Covid-19\", \"SARS-COV2\", \"Novel coronavirus\", \"2019-nCoV\", and \"smartphone\".",
            "cite_spans": [],
            "ref_spans": [],
            "section": "159"
        },
        {
            "text": "The articles were screened for relevance by title, abstract and eventually full-text review was performed for 162 included abstracts (Figure 1b) . Articles in languages other than English were excluded. Those studies in which 163 the subject matter was unrelated to the use of smartphone apps in Covid-19 were excluded. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 133,
                    "end": 144,
                    "text": "(Figure 1b)",
                    "ref_id": "FIGREF15"
                }
            ],
            "section": "161"
        },
        {
            "text": "The copyright holder for this preprint (which this version posted July 4, 2020. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "161"
        },
        {
            "text": "Apps from Asia scored higher in functionality (mean difference 0.54 (\u00b1 0.13) 95% CI= 0.3 to 0.8, p= information subscale (mean difference 0.6 (\u00b1 0.2) 95% CI= -1.0 to -0.1, p= 0.01). Aesthetics, engagement and 217 total scores did not differ between the western and Asian Apps. Thus, the apps based in the Indian subcontinent 218 were sufficiently interactive and functioned smoothly, but lacked in either quality, or quantity of information was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "214"
        },
        {
            "text": "The copyright holder for this preprint (which this version posted July 4, 2020. . https://doi.org/10.1101/2020.07.02.20144964 doi: medRxiv preprint study. For example, those articles which focused on specialty practice during COVID-19 and telemedicine, 299 smartphone enabled technology that did not involve an application, or studies that utilized apps to assess for 300 mental health outcomes among COVID-19 patients.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "214"
        },
        {
            "text": "A total of ten studies were found on this subject and have been detailed in was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "301"
        },
        {
            "text": "The copyright holder for this preprint (which this version posted July 4, 2020. . was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "301"
        },
        {
            "text": "The copyright holder for this preprint (which this version posted July 4, 2020. . https://doi.org/10.1101/2020.07.02.20144964 doi: medRxiv preprint was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Apps excluded (n=12) (inter-regional duplicates) All rights reserved. No reuse allowed without permission.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "301"
        },
        {
            "text": "was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. : Assesses the level of entertainment provided, whether interesting to use, lity, interactivity, and appropriateness of app content for target audience.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "301"
        },
        {
            "text": "ity: Assesses the performance, ease of use, navigation, and gestural design.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "301"
        },
        {
            "text": "Assesses the layout, quality of graphics, and overall visual appeal : Assesses the accuracy of the app description in the app store, whether the goals of the ific, measurable and achievable, quality and quantity of information, visual on of the information, source of information, and the level of evidence available for the pp All rights reserved. No reuse allowed without permission. was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "301"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "COVID-19 infection: Origin, transmission, and 2020",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Shereen",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Khan",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Kazmi",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Bashir",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Siddique",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Government of India. Aarogya Setu Mobile App | MyGov.in. my Gov. Accessed",
            "volume": "456",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Why is India's contact tracing app controversial?",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Biswas",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Soutik",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Why India's Covid-19 contact tracing app is controversial -BBC News",
            "authors": [
                {
                    "first": "Aarogya",
                    "middle": [],
                    "last": "Setu",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "466",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Peer-to-Peer Contact Tracing: Development of a Privacy",
            "authors": [
                {
                    "first": "T",
                    "middle": [
                        "M"
                    ],
                    "last": "Yasaka",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "M"
                    ],
                    "last": "Lehrich",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Sahyouni",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "study where we provide an overview of smartphone applications designed for COVID-19 through both a 116 literature search as well as a search of mobile platforms for applications. We describe the app features and 117 assessed their quality in terms of engagement, functionality, aesthetics, and information provided using the Services (NHS) Apps library and Myhealthapps.net. using the keywords-Covid, Corona, Pandemic, Covid-19, 123 SARS-COV2, Symptom, Health, Tracing, Novel coronavirus, 2019-nCoV, and Tracking. We limited our search 124 to applications released or updated for COVID-19 till May 5 th , 2020 and screened these applications for their 125 title, description of the application on mobile platforms, its functions around COVID-19 and then completed a 126 comprehensive assessment of these mobile applications (Figure 1a). Due to rapidly evolving nature of the 127 COVID-19 pandemic and language restrictions, we limited our search to the United States, United Kingdom and 128 India. Only those smartphone applications with the main subject matter as Covid-19 and in the languages",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "European, and North American apps with a p value of <0.05 considered as significant. Pearson's correlations 151 were used to analyse correlations between app downloads and MARS ratings. Microsoft excel was used search was conducted on PubMed (Medline), Cochrane central register for controlled trials, 156 Google Scholar and Turning Research Into Practice medical database from 9-10 th of May 2020 to identify peer-157 reviewed publications and grey literature on the utility of smartphone applications in the Covid-19 pandemic 158 and help aid our ongoing assessment of mobile platforms. 13",
            "latex": null,
            "type": "figure"
        },
        "FIGREF4": {
            "text": "identified 63 apps that were reviewed and performed a quality assessment on using the MARS scale.tracking of individuals (n=9), or ID with SSC (n=15), contact tracing alone (n=8), SSC (n=7), training of 179 healthcare workers (n=3), disinfection checklist (n=1), and service apps [Delivery or fund-raising] (n=2).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF5": {
            "text": "the apps, 27 (39%) were developed through federal efforts, 14 (21%) by commercial units, 5 (7%) by a 183 University, 1 (1%) by an NGO and 16 (24%) by unknown organisations/ entities (SupplementaryTable 2).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF6": {
            "text": "Data extraction for the number of downloads of the app was only possible on the android apps as that 185 information is not available on the Apple app store (AAS). The average star rating of apps on both the of app downloads ranged from 10+ to 50,000,000+. The most downloaded and reviewed app on the sub-scale. In comparison, Corona360 scored 1.6 in engagement, 3.3 in functionality, 3.3 in aesthetics and 2 in 209 information. Corona360 is an app developed by a private company, which aimed to create a map based visual 210 database of individuals infected with COVID-19 by allowing anonymous sharing of the users' status of infection 211 along with their approximate location. This app lacked methods of customisation or user engagement. The 212 singular graphic used in the app for a map with locations of infected individuals made it difficult to use and slow 213 to load, which might have contributed to low engagement.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF7": {
            "text": "219provided. In comparison, those apps developed in North America of the United Kingdom had credible, 220 necessary information, but lacked in creative methods of presentation of this information which could be 221 understood by the masses. A detailed analysis into each sub-scale was performed using the components of the 222 MARS scale 11 as previously described: should self-quarantine or go to a health care provider. Enough customisation was present in the 233 form of an edit function in self-screening history and the notification settings.234The Covid-19 UAE developed by the Ministry of Health UAE's official mobile app on Coronavirus 235 management provides users with real-time Coronavirus case information and keeps the app users engaged by 236 sharing news up to date with regional news and events. Its content presentation includes eye catching graphics 237 such as use of cartoon graphics representing viruses on top of each section. The app gives a color-coded 238 description of current status of patients: including newly diagnosed cases, deaths and those that recovered.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF8": {
            "text": "Moreover, it allows customisation to three different languages, including English, and a self-assessment section 240 for Covid-19.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF9": {
            "text": "Action Plan for Covid-19 was created by a private company and aimed to provide 242 information on the steps the country will take to tackle Covid-19. This app scored low in this section as it lacked 243 any form of graphics altogether. The information was present as a PDF with the only interaction being the 244 ability to change the pages and did not engage its users overall. eight apps scored a 5 in the functionality sub-scale. Of these, Jaano and COVA Punjab worked with 248 appropriate speed and switching between sections of the app was smooth. The menu labels and icons were 249 interactive and clear instructions and navigations made apps like Babylon-Healthcare service and 250 NHS24:Covid-19 easy to use and easily comprehendible.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF10": {
            "text": "251As for those apps which scored the lowest (<2.5), the main operation of the app did not work appropriately. For252 example, if the purpose of the app was to provide a map of infected individuals in the locality, COVID'19 and Odisha Covid Dashboard both available on the GPS and AAS, scored a 5 in this section. T 257 COVID'19 developed by Government of Telangana, India from provides updates regarding the cases and deaths 258 due to Covid-19, information about the nearest health centres, essential services, and Government 259 announcements, and allows self-symptom checks and tracking of infected individuals. The salient feature of this 260 application involves use of interactive icons used to depict different sub-sections of the app; for example, the 261 icon for 'telemedicine' included a doctor with a chat box next to him. Odisha COVID Dashboard utilises colour 262 All rights reserved. No reuse allowed without permission.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF11": {
            "text": "302focused towards development of smartphone app technology for contact tracing with the preservation of user 303 data, apps for information dissemination to healthcare workers in a region (n=1), and smartphone app enabled 304 technology for diagnostics. The more descriptive studies reviewed the evidence of the utility of smartphone apps 305 for COVID-19 based on countries' experiences (Table 2). Only one application included in our study, The306 COVID-19 Symptom Tracker mobile application, conducted an observational study to provide scientific 307 evidence of the app's utility. Through the application, they were able to acquire important information regarding 308 the population dynamics of the disease amongst the users. Comparisons between symptoms of users and test 309 results allowed generation of hypotheses for further research. Important results in their study demonstrated that 310 the app could predict in advance the COVID-19 incidence of a region. knowledge, our study is one of the first to perform a comprehensive assessment of mobile applications 314 being used during the COVID-19 pandemic. Smartphone applications have an immense potential to control the 315 spread of misinformation associated with the COVID-pandemic, raise awareness, allow contact tracing and 316 finally, help improve provision of the preventive and clinical care of patients. We identified 63 mobile 317 applications from different regions which scored across the MARS continuum and differed in terms of their 318 functionality, aesthetics, information sharing and overall purpose. The app downloads did not correlate with 319 quality, suggesting the need to revisit the app usage strategies among individuals and advisories by federal or320 health authorities.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF13": {
            "text": "on their functioning without considering features that make the app equally engaging and important to an325 increased userbase. Moreover, the large number of apps delegated by various countries and organisations could 326 potentially cause confusion amongst users regarding the utility and preference. The fact that the app quality did 327 not correlate with downloads supports this possibility. Moreover, extending the usage of quality apps designed 328 in one region to others may be a cost-efficient and relevant administrative exercise in the face of a global 329 economic collapse. We identified Covid-19 UAE, NHS24:Covid-19, Odisha Covid Dashboard, and 1-Check 330 COVID as exemplary apps in the engagement, functionality, aesthetics, and information domains respectively.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF14": {
            "text": "Interestingly, the apps developed in Asia were user-friendly and designed to ensure that most of the 332 users understood the application and used it effectively. With over 500,000,000 smartphone users in this333 country 15 and considerable variations in socioeconomic status including differences in education attainment 334 these characteristics are extremely necessary to be considered in developing a user-friendly app. On the other exercised while interpreting the results portrayed in this review. In addition, there is a likelihood that the 384 features of the apps portrayed by us are different from the updated versions of the app and might have been 385 addressed in apps developed after this review. This possibility is inevitable considering the rapidity with which 386 apps are developed and reformed. recent Covid-times, the market has seen the appearance of numerous mobile-applications for tracking and 391 managing the pandemic. The app-market remains disorganized and unregulated in several countries. The present 392 review provides an overview of mobile applications available in United Kingdom, USA and India; summarize 393 their strengths and limitations through a qualitative assessment; and delineates key functions and features 394 needed for future applications. Rapid population-based longitudinal studies and randomized trials would 395 characterize the use and efficacy of mobile apps on health knowledge, behaviours and use to limit the spread of 396 COVID-19 and help reduce its burden on the public health and clinical systems.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF15": {
            "text": "PRISMA-Literature search 405",
            "latex": null,
            "type": "figure"
        },
        "FIGREF16": {
            "text": "MARS",
            "latex": null,
            "type": "figure"
        },
        "FIGREF17": {
            "text": "Map App. JMIR MHealth UHealth. 2020;8(4):e18936. doi:10.2196/18936 469 21. Abeler J, B\u00e4cker M, Buermeyer U, Zillessen H. COVID-19 Contact Tracing and Data Protection Can Go 470 Together. JMIR MHealth UHealth. 2020;8(4):e19359. doi:10.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF18": {
            "text": "Figure 2: MARS structure",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "Majority of ongoing research",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "App quality ratings",
            "latex": null,
            "type": "table"
        },
        "TABREF2": {
            "text": "Literature search results. Supplementary Table 1: Discrepancies resolved while eliminating apps by name and abstract review Supplementary Table 2: Characteristics of apps assessed using the MARS",
            "latex": null,
            "type": "table"
        },
        "TABREF3": {
            "text": "Subject matter unrelated to Covid-19 (Games, books, photography and videography)",
            "latex": null,
            "type": "table"
        },
        "TABREF4": {
            "text": "The copyright holder for this preprint (which this version posted July 4, 2020.. https://doi.org/10.1101/2020.07.02.20144964Records excluded Content unrelated to the study (n=43) All rights reserved. No reuse allowed without permission.was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "latex": null,
            "type": "table"
        },
        "TABREF5": {
            "text": "The copyright holder for this preprint (which this version posted July 4, 2020. . https://doi.org/10.1101/2020.07.02.20144964All rights reserved. No reuse allowed without permission.was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint (which this version posted July 4, 2020. . https://doi.org/10.1101/2020.07.02.20144964",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}